AI Analysis
AI-generated analysis. Always verify with the original filing.
Innate Pharma S.A. announced a conference call and webcast on March 26, 2026 at 2 p.m. CET / 9 a.m. EDT following the release of its full year 2025 financial results ending December 31, 2025. The event features key executives including CEO Jonathan Dickinson and a replay will be available on the company website for 90 days.
Key Takeaways
1Conference call scheduled for March 26, 2026 at 2 p.m. CET / 9 a.m. EDT
2Participants include Jonathan Dickinson (CEO), Sonia Quaratino (EVP, Chief Medical Officer), Yannis Morel (EVP, Chief Operating Officer), Stéphanie Cornen (VP, Investor Relations), Frédéric Lombard (SVP, CFO)
3Live webcast at https://events.q4inc.com/attendee/704730270
4Telephone registration at https://events.q4inc.com/analyst/704730270?pwd=usHLLD39
5Webcast replay available on www.innate-pharma.com for 90 days